Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 249

Similar articles for PubMed (Select 23813132)

1.

Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.

Genc H, Dogru T, Kara M, Tapan S, Ercin CN, Acikel C, Karslioglu Y, Bagci S.

Ann Hepatol. 2013 Jul-Aug;12(4):548-55.

2.

Adipokines and cytokines in non-alcoholic fatty liver disease.

Jarrar MH, Baranova A, Collantes R, Ranard B, Stepanova M, Bennett C, Fang Y, Elariny H, Goodman Z, Chandhoke V, Younossi ZM.

Aliment Pharmacol Ther. 2008 Mar 1;27(5):412-21. Epub 2007 Dec 10.

3.

Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.

Polyzos SA, Kountouras J, Papatheodorou A, Katsiki E, Patsiaoura K, Zafeiriadou E, Papadopoulou E, Zavos C, Terpos E.

Ann Hepatol. 2013 Sep-Oct;12(5):749-57.

4.

Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.

Auguet T, Terra X, Porras JA, Orellana-Gavaldà JM, Martinez S, Aguilar C, Lucas A, Pellitero S, Hernández M, Del Castillo D, Richart C.

Clin Biochem. 2013 Feb;46(3):202-8. doi: 10.1016/j.clinbiochem.2012.11.006. Epub 2012 Nov 19.

PMID:
23174488
6.

Visceral adipose tissue visfatin in nonalcoholic fatty liver disease.

Gaddipati R, Sasikala M, Padaki N, Mukherjee RM, Sekaran A, Jayaraj-Mansard M, Rabella P, Rao-Guduru V, Reddy-Duvvuru N.

Ann Hepatol. 2010 Jul-Sep;9(3):266-70.

PMID:
20720266
7.

Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.

Agueda M, Lasa A, Simon E, Ares R, Larrarte E, Labayen I.

Nutr Metab Cardiovasc Dis. 2012 Mar;22(3):208-14. doi: 10.1016/j.numecd.2010.06.010. Epub 2010 Oct 14.

PMID:
20951014
8.

Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.

de Boer JF, Bahr MJ, Böker KH, Manns MP, Tietge UJ.

Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G196-201. doi: 10.1152/ajpgi.00029.2008. Epub 2008 Dec 12.

9.

Elevated visfatin levels in obese children are related to proinflammatory factors.

Li RZ, Ma Xn, Hu XF, Kang SX, Chen SK, Cianflone K, Lu HL.

J Pediatr Endocrinol Metab. 2013;26(1-2):111-8.

PMID:
23327785
10.

Visfatin levels in nonalcoholic fatty liver disease.

Akbal E, Koçak E, Taş A, Yüksel E, Köklü S.

J Clin Lab Anal. 2012 Feb;26(2):115-9. doi: 10.1002/jcla.21491.

PMID:
22467327
11.

[Evaluation of serum visfatin concentrations in children with nonalcoholic fatty liver disease].

Romanowska A, Lebensztejn DM.

Pol Merkur Lekarski. 2010 Jun;28(168):459-61. Polish.

PMID:
20642104
12.

The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.

Erten Y, Ebinç FA, Ebinç H, Paşaoğlu H, Demirtaş C, Taçoy G, Koç E, Derici U, Reis KA, Bali M, Arinsoy T, Sindel S.

Ren Fail. 2008;30(6):617-23. doi: 10.1080/08860220802134573.

PMID:
18661412
13.

Circulating visfatin level is correlated with inflammation, but not with insulin resistance.

Oki K, Yamane K, Kamei N, Nojima H, Kohno N.

Clin Endocrinol (Oxf). 2007 Nov;67(5):796-800. Epub 2007 Jul 18.

PMID:
17634078
14.

Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C.

Hung CH, Lee CM, Chen CH, Hu TH, Jiang SR, Wang JH, Lu SN, Wang PW.

Liver Int. 2009 Aug;29(7):1086-93. doi: 10.1111/j.1478-3231.2009.01991.x. Epub 2009 Mar 3.

PMID:
19302182
15.

Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease.

Aller R, de Luis DA, Izaola O, Sagrado MG, Conde R, Velasco MC, Alvarez T, Pacheco D, González JM.

Dig Dis Sci. 2009 Aug;54(8):1772-7. doi: 10.1007/s10620-008-0539-9. Epub 2008 Nov 14.

PMID:
19005759
16.

Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.

Nayak BS, Ramsingh D, Gooding S, Legall G, Bissram S, Mohammed A, Raychaudhuri A, Sahadeo B, Pandohie V, Figaro K.

Prim Care Diabetes. 2010 Oct;4(3):187-92. doi: 10.1016/j.pcd.2010.05.006. Epub 2010 Jun 30.

PMID:
20580627
17.

Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease.

Kumar R, Prakash S, Chhabra S, Singla V, Madan K, Gupta SD, Panda SK, Khanal S, Acharya SK.

Indian J Med Res. 2012 Aug;136(2):229-36.

18.

Circulating pro-inflammatory cytokines and adiponectin in young men with type 2 diabetes.

Su SC, Pei D, Hsieh CH, Hsiao FC, Wu CZ, Hung YJ.

Acta Diabetol. 2011 Jun;48(2):113-9. doi: 10.1007/s00592-009-0171-y. Epub 2010 Jan 8.

PMID:
20058158
19.

Visfatin and endothelial function in dialyzed patients.

Malyszko J, Malyszko JS, Mysliwiec M.

Nephrology (Carlton). 2010 Mar;15(2):190-6. doi: 10.1111/j.1440-1797.2009.01180.x.

PMID:
20470278
20.

Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.

Lemoine M, Ratziu V, Kim M, Maachi M, Wendum D, Paye F, Bastard JP, Poupon R, Housset C, Capeau J, Serfaty L.

Liver Int. 2009 Oct;29(9):1431-8. doi: 10.1111/j.1478-3231.2009.02022.x. Epub 2009 Apr 24.

PMID:
19422483
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk